SOURCE: SoundCure, Inc.

SoundCure, Inc.

April 15, 2013 03:00 ET

SoundCure® Launches the Serenade® Tinnitus Treatment System in the UK

Customized Sound Therapy Approach for Ringing Ears, With Novel Treatment Sounds

SAN JOSE, CA--(Marketwired - Apr 15, 2013) - SoundCure Inc., a tinnitus solution provider, today announced the launch of the Serenade Tinnitus Treatment System at the upcoming Association of Independent Hearing Healthcare Practitioners (AIHHP) spring conference. Serenade was launched in the U.S. in April, 2012, and is now offered by hundreds of audiologists and hearing healthcare providers nationwide. This UK launch marks the first formal commercial release outside the U.S. of this novel advancement in sound therapy. Serenade offers tinnitus sufferers potential relief using S-Tones®, customized treatment sounds developed independently by leading hearing researchers at the University of California.

Tinnitus, or "ringing ears," affects approximately 10% of U.K. adults and an estimated 260 million people globally. It can be extremely debilitating, leading to depression, irritability, and difficulty sleeping or concentrating.

Serenade is a handheld device that is programmed in the clinician's office for each individual patient according to his specific condition. Through the device's earphones, the patient listens to therapeutic sounds which are designed to address the underlying neurological cause of tinnitus. Four different treatment sounds are available, anchored by advanced, proprietary S-Tones. Long-term relief can be achieved when used in an ongoing sound therapy program.

Sound therapy as a tinnitus treatment is well-established and effective. S-Tones are low frequency, amplitude modulated tones that are frequency pitch-matched to a patient's unique tinnitus, representing a significant clinical breakthrough compared to previous approaches. According to Dr. Fan-Gang Zeng, one of the technology inventors, these modulated tones "keep the brain's interest" thus "reducing the perceived tinnitus sound and bringing relief." In addition, S-Tones are intended to be "listened to at a volume that is lower than the patient's tinnitus, reducing the sound burden," according to Dr. Zeng.

SoundCure CEO Bill Perry states, "We are proud and excited to make the Serenade technology and tinnitus management approach available to a wider audience, and look forward to being part of the solution for tinnitus sufferers in the UK."

About SoundCure, Inc.

Established in 2009 to commercialize the technology developed for years at the University of California, Irvine, SoundCure, Inc. is a privately held medical device company whose mission is to revolutionize the treatment of tinnitus and provide relief to the millions of people suffering its effects. SoundCure is an Allied Minds company. www.soundcure.com

Contact Information

  • Media Contact:
    Barbara Cromarty
    SoundCure Inc.
    (408) 938-5743
    Email Contact